AI-generated analysis. Always verify with the original filing.
Tonix Pharmaceuticals Holding Corp. filed an 8-K on March 13, 2026, disclosing results of operations via Exhibit 99.01 press release dated March 12, 2026. Item 2.02 and Item 9.01 are referenced, with the earnings information not deemed 'filed' for Section 18 purposes.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K, including Exhibit 99.01 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the United States Securit
Financial Statements and Exhibits. (d) Exhibit No. Description. 99.01 Press Release of the Company, March 12, 2026 104 Cover Page Interactive Data File (embedde